EP3528817
Aðferðir til að meðhöndla lifrarraskanir eða lípíðraskanir með THR-betaörva
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.10.2017EP published:
25.5.2022EP application number:
17804979.7
EP translation filed:
8.8.2022Grant published:
15.9.2022EPO information:
European Patent Register
Max expiry date:
17.10.2037Expiry date:
17.10.2026Next due date:
31.10.2026
Title in English:
METHODS OF TREATING LIVER DISORDERS OR LIPID DISORDERS WITH A THR-BETA AGONISTLanguage of the patent:
English
Timeline
Today
18.10.2017EP application
25.5.2022EP Publication
8.8.2022Translation submitted
15.9.2022Registration published
17.10.2026Expires
Owner
Name:
Madrigal Pharmaceuticals, Inc.Address:
200 Barr Harbor Drive, Suite 400, West Conshohocken, Pennsylvania 19428, US
Inventor
Name:
TAUB, RebeccaAddress:
Villanova PA 19085, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662409833 PDate:
18.10.2016Country:
US
Number:
201762516594 PDate:
7.6.2017Country:
US
Classification
Categories:
A61K 31/53, A61P 1/16, A61P 3/06, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 3.10.2022
Expires: 17.10.2023
Payer: Patice ehf.
Number: 7
Paid: 19.10.2023
Expires: 17.10.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 31.10.2024
Expires: 17.10.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 14.10.2025
Expires: 17.10.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 14.10.2025
Expires: 17.10.2026
Payer: Árnason Faktor ehf.